Unique Severe COVID-19 Placental Signature Independent of Severity of Clinical Maternal Symptoms

被引:35
|
作者
Husen, Marjolein F. [1 ]
van der Meeren, Lotte E. [2 ,3 ]
Verdijk, Robert M. [3 ,4 ]
Fraaij, Pieter L. A. [5 ,6 ]
van der Eijk, Annemiek A. [5 ]
Koopmans, Marion P. G. [6 ]
Freeman, Liv [7 ]
Bogers, Hein [8 ]
Trietsch, Marjolijn D. [9 ]
Reiss, Irwin K. M. [10 ]
DeKoninck, Philip L. J. [1 ]
Schoenmakers, Sam [1 ]
机构
[1] Univ Med Ctr, Dept Obstet & Gynaecol, Erasmus MC, NL-3015 GD Rotterdam, Netherlands
[2] Leiden Univ Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands
[3] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands
[4] Univ Med Ctr, Dept Pathol, Erasmus MC, NL-3015 GD Rotterdam, Netherlands
[5] Univ Med Ctr, Dept Virosci, Erasmus MC, NL-3015 GD Rotterdam, Netherlands
[6] Erasmus MC, Dept Pediat Infectiol Immunol & Rheumatol, NL-3015 GD Rotterdam, Netherlands
[7] Ikazia Hosp, Dept Obstet & Gynaecol, NL-3083 AN Rotterdam, Netherlands
[8] Franciscus Vlietland Hosp, Dept Obstet & Gynaecol, NL-3045 PM Rotterdam, Netherlands
[9] Leiden Univ Med Ctr, Dept Obstet & Gynaecol, NL-2333 ZA Leiden, Netherlands
[10] Univ Med Ctr, Dept Neonatol, Erasmus MC, NL-3015 GD Rotterdam, Netherlands
来源
VIRUSES-BASEL | 2021年 / 13卷 / 08期
关键词
placenta; SARS-CoV-2; pregnancy; foetal outcome; UNKNOWN ETIOLOGY; CHRONIC INTERVILLOSITIS; REPRODUCIBILITY; INFLAMMATION; INFECTION; PATHOLOGY; NOSOLOGY; VILLITIS; LESIONS; WOMEN;
D O I
10.3390/v13081670
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Although the risk for transplacental transmission of SARS-CoV-2 is rare, placental infections with adverse functional consequences have been reported. This study aims to analyse histological placental findings in pregnancies complicated by SARS-CoV-2 infection and investigate its correlation with clinical symptoms and perinatal outcomes. We want to determine which pregnancies are at-risk to prevent adverse pregnancy outcomes related to COVID-19 in the future. Methods: A prospective, longitudinal, multicentre, cohort study. All pregnant women presenting between April 2020 and March 2021 with a nasopharyngeal RT-PCR-confirmed SARS-CoV-2 infection were included. Around delivery, maternal, foetal and placental PCR samples were collected. Placental pathology was correlated with clinical maternal characteristics of COVID-19. Results: Thirty-six patients were included, 33 singleton pregnancies (n = 33, 92%) and three twin pregnancies (n = 3, 8%). Twenty-four (62%) placentas showed at least one abnormality. Four placentas (4/39, 10%) showed placental staining positive for the presence of SARS-CoV-2 accompanied by a unique combination of diffuse, severe inflammatory placental changes with massive perivillous fibrin depositions, necrosis of syncytiotrophoblast, diffuse chronic intervillositis, and a specific, unprecedented CD20+ B-cell infiltration. This SARS-CoV-2 placental signature seems to correlate with foetal distress (75% vs. 15.6%, p = 0.007) but not with the severity of maternal COVID-19 disease. Conclusion: We describe a unique placental signature in pregnant patients with COVID-19, which has not been reported in a historical cohort. We show that the foetal environment can be seriously compromised by disruption of placental function due to local, devastating SARS-CoV-2 infection. Maternal clinical symptoms did not predict the severity of the SARS-CoV-2-related placental signature, resulting in a lack of adequate identification of maternal criteria for pregnancies at risk. Close foetal monitoring and pregnancy termination in case of foetal distress can prevent adverse pregnancy outcomes due to COVID-19 related placental disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] An inflammatory cytokine signature predicts COVID-19 severity and survival
    Del Valle, Diane Marie
    Kim-Schulze, Seunghee
    Huang, Hsin-Hui
    Beckmann, Noam D.
    Nirenberg, Sharon
    Wang, Bo
    Lavin, Yonit
    Swartz, Talia H.
    Madduri, Deepu
    Stock, Aryeh
    Marron, Thomas U.
    Xie, Hui
    Patel, Manishkumar
    Tuballes, Kevin
    Van Oekelen, Oliver
    Rahman, Adeeb
    Kovatch, Patricia
    Aberg, Judith A.
    Schadt, Eric
    Jagannath, Sundar
    Mazumdar, Madhu
    Charney, Alexander W.
    Firpo-Betancourt, Adolfo
    Mendu, Damodara Rao
    Jhang, Jeffrey
    Reich, David
    Sigel, Keith
    Cordon-Cardo, Carlos
    Feldmann, Marc
    Parekh, Samir
    Merad, Miriam
    Gnjatic, Sacha
    NATURE MEDICINE, 2020, 26 (10) : 1636 - +
  • [22] COVID-19 as an independent risk factor for subclinical placental dysfunction
    Jaiswal, Nishtha
    Puri, Manju
    Agarwal, Kiran
    Singh, Smita
    Yadav, Reena
    Tiwary, Narendra
    Tayal, Prerna
    Vats, Barkha
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 259 : 7 - 11
  • [23] Diagnostic role of laboratory findings and clinical symptoms in detecting the severity of COVID-19 disease
    Alshipli, M.
    Altaim, T. A.
    Khodrog, O.
    Hawamdeh, M.
    Alsenany, S. A.
    Abdelaliem, S. M. F.
    Marashdeh, M.
    Hammudeh, T.
    Alnawafleh, T.
    Gaowgzeh, R. A. M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (12) : 5909 - 5917
  • [24] The correlation between humoral immune responses and severity of clinical symptoms in COVID-19 patients
    Akbarian, Shadi
    Sheikhi, Mehdi
    Khedri, Parichehr
    Baharifar, Narges
    Khalaf Shamsabadi, Fatemeh
    Davidi, Mohammad Reza
    Khazaei, Hossein Ali
    Assarian, Hamidali
    Sheikhi, Abdolkarim
    EPIDEMIOLOGY & INFECTION, 2023, 151
  • [25] Clinical Features and Upper Airway Symptoms in Association with Severity and Outcome in Patients with COVID-19
    Hadi, Furaq Hussain
    Kadhim, Iman Jabbar
    Deli, Falah Abdulhasan
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2022, 8 (02): : 140 - 146
  • [26] Impact of Covid-19 on risk of severe maternal morbidity
    Auger, Nathalie
    Ukah, U. Vivian
    Wei, Shu Qin
    Healy-Profitos, Jessica
    Lo, Ernest
    Dayan, Natalie
    CRITICAL CARE, 2023, 27 (01)
  • [27] Impact of Covid-19 on risk of severe maternal morbidity
    Nathalie Auger
    U. Vivian Ukah
    Shu Qin Wei
    Jessica Healy-Profitós
    Ernest Lo
    Natalie Dayan
    Critical Care, 27
  • [28] Specific Features of the Coagulopathy Signature in Severe COVID-19 Pneumonia
    Blot, Mathieu
    de Maistre, Emmanuel
    Bourredjem, Abderrahmane
    Quenot, Jean-Pierre
    Nguyen, Maxime
    Bouhemad, Belaid
    Charles, Pierre-Emmanuel
    Binquet, Christine
    Piroth, Lionel
    FRONTIERS IN MEDICINE, 2021, 8
  • [29] Residual symptoms in moderate to severe COVID-19 patients
    Elfidha, Sabrine
    Louhaichi, Sabrine
    Khalfallah, Ikbel
    Marzouki, Safa
    Kaabi, Line
    Jebeli, Rihab
    Kharrat, Mohamed Ali
    Ammar, Jamel
    Hamdi, Besma
    Hamzaoui, Agnes
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [30] Cytokine Storm Signature in Patients with Moderate and Severe COVID-19
    Kalinina, Olga
    Golovkin, Alexey
    Zaikova, Ekaterina
    Aquino, Arthur
    Bezrukikh, Vadim
    Melnik, Olesya
    Vasilieva, Elena
    Karonova, Tatiana
    Kudryavtsev, Igor
    Shlyakhto, Evgeny
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)